Related Experiment Video

Updated: Apr 9, 2026

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
02:21

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

2.0K

[APPLICATION OF AUTOPLASMA ENRICHED WITH PLATELET DERIVED GROWTH FACTOR IN THE TREATMENT OF ERECTILE DYSFUNCTION]

P V Glybochko, M E Chaly, M V Yepifanova

    Urologiia (Moscow, Russia : 1999)
    |June 23, 2015
    PubMed

    More Related Videos

    Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion08:34

    Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion

    Published on: February 24, 2021

    3.1K
    Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia03:22

    Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

    Published on: January 27, 2018

    15.9K

    Related Concept Videos

    Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

    Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

    Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
    Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
    749
    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

    Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
    These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
    615